Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News XenoPort XNPT

Healthcare Biotechnology
"XenoPort Inc is a biopharmaceutical company. It is engaged in developing and commercializing a portfolio of internally discovered product candidates for the treatment of neurological and other disorders."

Recent & Breaking News (NDAQ:XNPT)

Hostess Brands, Maker of Twinkies®, Announces Sale Agreement with Gores Holdings, Inc.

Business Wire July 5, 2016

Arbor Pharmaceuticals Completes Successful Tender Offer for Shares of XenoPort

Business Wire July 5, 2016

Why Investors Love These Biotech's Stocks? - Cellectar Biosciences, Xenoport, Rexahn Pharma, and Tesaro

PR Newswire June 29, 2016

Lifshitz & Miller Law Firm Announces Investigation of Exterran Corporation, inContact, Inc., LinkedIn Corporation, Mines Management, Inc., Rose Rock Midstream, L.P., STAAR Surgical Company, XenoPort, Inc. and Your Community Bankshares, Inc.

PR Newswire June 20, 2016

Arbor Pharmaceuticals and XenoPort Announce the Expiration of the HSR Act Waiting Period

Business Wire June 16, 2016

XENOPORT SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Xenoport, Inc. (XNPT) Over the Proposed Sale of the Company to Arbor Pharmaceuticals, LLC

Business Wire May 26, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning Whether the Sale of XenoPort, Inc. to Arbor Pharmaceuticals, LLC for $7.03 Per Share is Fair to Shareholders -- XNPT

PR Newswire May 25, 2016

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of XenoPort, Inc. and Encourages Investors to Contact the Firm for Additional Information

Business Wire May 24, 2016

SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Proposed Sale of Xura, Inc. and Encourages Investors to Contact the Firm for Additional Information

Business Wire May 24, 2016

SHAREHOLDER ALERT: Pomerantz LLP Investigates Claims That the Merger May Not Be in the Best Interest of Investors of XenoPort Inc. - XNPT

PR Newswire May 24, 2016

Ryan & Maniskas, LLP Announces Investigation of XenoPort, Inc.

PR Newswire May 24, 2016

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of The Board of Directors of XenoPort, Inc. -XNPT

PR Newswire May 23, 2016

Harwood Feffer LLP Announces Investigation of XenoPort, Inc.

PR Newswire May 23, 2016

XENOPORT, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie Briscoe and Powers Taylor LLP Believe the Acquisition by Arbor Pharmaceuticals, LLC May Be Unfair to Shareholders

Business Wire May 23, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation as to Whether the Sale of Xenoport, Inc. to Arbor Pharmaceuticals, LLC for $7.03 Per Share is Fair to Shareholders - XNPT

Accesswire May 23, 2016

XENOPORT, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout

Business Wire May 23, 2016

XENOPORT (XNPT) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of XenoPort, Inc.; Are Shareholders Getting a Fair Price?

PR Newswire May 23, 2016

Arbor Pharmaceuticals to Acquire XenoPort

Business Wire May 23, 2016

XenoPort Reports First Quarter Financial Results

Business Wire May 5, 2016

XenoPort to Release First Quarter Financial Results on May 5, 2016

Business Wire April 26, 2016